61 related articles for article (PubMed ID: 30147623)
1. Role of Transforming Growth Factor 1 in Lymphocyte Development and Death.
Bommireddy R; Ormsby I; Yin M; Doetschman TC
ScientificWorldJournal; 2001; 1():146. PubMed ID: 30147623
[No Abstract] [Full Text] [Related]
2. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein.
Hashimoto Y; Chiba T; Yamada M; Nawa M; Kanekura K; Suzuki H; Terashita K; Aiso S; Nishimoto I; Matsuoka M
Mol Cell Biol; 2005 Nov; 25(21):9304-17. PubMed ID: 16227582
[TBL] [Abstract][Full Text] [Related]
4. Role of epidermal growth factor and transforming growth factors in mammary development and lactation.
Plaut K
J Dairy Sci; 1993 Jun; 76(6):1526-38. PubMed ID: 8326026
[TBL] [Abstract][Full Text] [Related]
5. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta.
Kee BL; Rivera RR; Murre C
Nat Immunol; 2001 Mar; 2(3):242-7. PubMed ID: 11224524
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells Suppress Chronic Rejection in Heterotopic Small Intestine Transplant Rat Models Via Inhibition of CD68, Transforming Growth Factor- β1, and Platelet-Derived Growth Factor Expression.
Li F; Cao J; Zhao Z; Li C; Qi F; Liu T
Exp Clin Transplant; 2017 Apr; 15(2):213-221. PubMed ID: 28338461
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
Nattermann J; Vogel M; Nischalke HD; Danta M; Ahlenstiel G; Michalk M; Sauerbruch T; Rockstroh JK; Spengler U;
AIDS; 2008 Jul; 22(11):1287-92. PubMed ID: 18580607
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 serves as an autocrine inhibitor of human endothelial cell/lymphocyte adhesion.
Rhodes JM; Engelmyer E; Tilberg AF; Gifford RR
J Surg Res; 1995 Dec; 59(6):719-24. PubMed ID: 8538171
[TBL] [Abstract][Full Text] [Related]
9. TGF beta2-induced changes in LRP-1/T beta R-V and the impact on lysosomal A beta uptake and neurotoxicity.
Eslami P; Johnson MF; Terzakaryan E; Chew C; Harris-White ME
Brain Res; 2008 Nov; 1241():176-87. PubMed ID: 18804458
[TBL] [Abstract][Full Text] [Related]
10. The effect of transforming growth factor-alpha on airway angiogenesis.
Schraufnagel DE; Arzouman DA; Sekosan M; Ho YK
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1582-8. PubMed ID: 1280750
[TBL] [Abstract][Full Text] [Related]
11. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.
Sterlacci W; Wolf D; Savic S; Hilbe W; Schmid T; Jamnig H; Fiegl M; Tzankov A
Hum Pathol; 2012 Mar; 43(3):339-49. PubMed ID: 21840566
[TBL] [Abstract][Full Text] [Related]
12. Wound healing in the transforming growth factor-beta-deficient mouse.
Brown RL; Ormsby I; Doetschman TC; Greenhalgh DG
Wound Repair Regen; 1995; 3(1):25-36. PubMed ID: 17168860
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte proliferation induced by pertussis toxin utilizes a pathway parallel to transforming growth factor-beta-sensitive growth.
Cronkhite RI
Int Arch Allergy Immunol; 1993; 102(2):141-3. PubMed ID: 8400894
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta induces human T lymphocyte migration in vitro.
Adams DH; Hathaway M; Shaw J; Burnett D; Elias E; Strain AJ
J Immunol; 1991 Jul; 147(2):609-12. PubMed ID: 2071897
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
[TBL] [Abstract][Full Text] [Related]
17. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
[TBL] [Abstract][Full Text] [Related]
18. Role of mutation and pharmacologic block of human KCNH2 in vasculogenesis and fetal mortality: partial rescue by transforming growth factor-β.
Teng G; Zhao X; Lees-Miller JP; Belke D; Shi C; Chen Y; O'Brien ER; Fedak PW; Bracey N; Cross JC; Duff HJ
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):420-8. PubMed ID: 25648353
[TBL] [Abstract][Full Text] [Related]
19. Wound healing in the fetus. Possible role for inflammatory macrophages and transforming growth factor-beta isoforms.
Longaker MT; Bouhana KS; Harrison MR; Danielpour D; Roberts AB; Banda MJ
Wound Repair Regen; 1994; 2(2):104-12. PubMed ID: 17134379
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal interactions and lung branching morphogenesis. Role of polyamines and transforming growth factor beta1.
Stabellini G; Locci P; Calvitti M; Evangelisti R; Marinucci L; Bodo M; Caruso A; Canaider S; Carinci P
Eur J Histochem; 2001; 45(2):151-62. PubMed ID: 11512636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
